Purpose: Lateral knee osteoarthritis (OA) is observed in more than 50% of people with knee OA after anterior cruciate ligament reconstruction (ACLR). Lateral and medial knee OA are associated with different gait knee mechanics. Lateral knee OA is associated with lower peak external knee adduction moments than medial knee OA. Thus, it is important to investigate targeted interventions with the potential to address abnormal knee mechanics associated with lateral knee OA following ACLR. The aim of this study was to investigate the immediate effects of a varus unloader brace on knee kinematics and moments in people with predominant lateral knee OA and valgus malalignment after ACLR. Methods: Nineteen participants who had undergone a primary ACLR 5-20 years previously, with symptomatic (Knee Injury and Osteoarthritis Outcome Score (KOOS) criteria) and radiographic (Kellgren & Lawrence !2) lateral knee OA and valgus malalignment were recruited from the community in Melbourne, Australia. Quantitative gait analyses were conducted during walking trials at self-selected speeds, under three test conditions in a randomized order: i) no brace; ii) unadjusted brace (sagittal plane support, no varus adjustment); and iii) adjusted brace (sagittal plane support with varus adjustment). Participants rated their average level of knee pain on visual analogue scales upon completion of each test condition. Postprocessing of gait data involved calculation of knee kinematics, ground reaction forces and external joint moments for the reconstructed limb. First and second peak values were identified during stance phase. Data were statistically analyzed using repeated measures analysis of variance (p<0.05). Results: The cohort consisted of 15 (79%) males (meanAESD age 37AE7yrs, height 1.72AE0.06m, body weight 80AE10kg; KOOS subscales: pain 80AE15, symptoms 74AE13, activities of daily living 88AE15, sport/ recreation 69AE26, quality of life 58AE23). There were no significant differences in knee pain between the three test conditions (p¼0.655). Compared to the no brace condition, the adjusted brace resulted in immediate increases in the first peak knee flexion angle (mean difference, 95% confidence interval: -3.2 , -5.0 to -1.3) and moment at peak 1 (-1.0 Nm/kg, -1.5 to -0.5) and peak 2 (-0.8 Nm/kg, -1.3 to -0.4), increases in peak 1 and peak 2 knee adduction angles (-2.5 , -3.6 to -1.3; 2.6 , -3.7 to -1.4, respectively) and moments (-0.7 Nm/kg, -1.0 to -0.5; -0.7 Nm/kg, -1.0 to -0.4, respectively). Increases in peak 1 and peak 2 knee internal rotation angles (2.9 , 1.9 to 3.8; 3.3 , 2.1 to 4.6, respectively) and reduction in peak 1 internal rotation moment (-0.08 Nm/kg, -0.13 to -0.02) were noted with the adjusted brace. The unadjusted brace produced similar immediate changes in knee kinematics and moments. The unadjusted brace increased peak 1 knee flexion angle (-3.4 , -5.0 to -1.8) and moment (-1.2 Nm/kg, -1.7 to -0.7), increased both knee adduction angle peaks (peak 1: -2.0 , -3.2 to -0.9; peak 2: -2.3, -3.4 to -1.2) and moment peaks (peak 1: -0.7 Nm/kg, -1.0 to -0.4; peak 2: -0.8 Nm/kg, -1.3 to -0.4). The unadjusted brace also reduced peak 1 and peak 2 internal rotation angles (1.5 , 0.7 to 2.3; 2.4 , 1.3 to 3.6, respectively) and increased peak 1 internal rotation moment (-0.1 Nm/kg, -0.2 to -0.04). Compared to the unadjusted brace, the adjusted brace produced significantly reductions in both peak internal rotation angles (peak 1: -1.4 , -1.9 to -0.9; peak 2: -0.9 , -1.5 to -0.2 (Figure 1) . Conclusion: Knee bracing significantly increased peak sagittal and frontal plane kinematics and moments at the knee joint, and reduced peak transverse plane kinematics and increased transverse plane moments in people with knee OA after ACLR. The varus adjusted brace produced more pronounced changes in frontal and transverse plane kinematics than the unadjusted brace. In younger individuals with predominant lateral knee OA and valgus malalignment after ACLR, the varus unloader brace may be able to mitigate abnormal knee joint mechanics. The long-term effect of this on progression of lateral compartment degenerative joint disease following ACLR requires further investigation. 50 AUTOPHAGY CHANGES DURING AGING: A STUDY IN GFP-LC3 MICE B. Carames y , z, W. kiosses z, M. Olmer z, M. Lotz z. y Osteoarticular and Aging Res. Lab, INIBIC-Complejo Hosp.ario Univ.rio A Coruña, A CORUÑA, Spain; z The Scripps Res. Inst., La Jolla, CA, USA
Purpose: Lateral knee osteoarthritis (OA) is observed in more than 50% of people with knee OA after anterior cruciate ligament reconstruction (ACLR). Lateral and medial knee OA are associated with different gait knee mechanics. Lateral knee OA is associated with lower peak external knee adduction moments than medial knee OA. Thus, it is important to investigate targeted interventions with the potential to address abnormal knee mechanics associated with lateral knee OA following ACLR. The aim of this study was to investigate the immediate effects of a varus unloader brace on knee kinematics and moments in people with predominant lateral knee OA and valgus malalignment after ACLR. Methods: Nineteen participants who had undergone a primary ACLR 5-20 years previously, with symptomatic (Knee Injury and Osteoarthritis Outcome Score (KOOS) criteria) and radiographic (Kellgren & Lawrence !2) lateral knee OA and valgus malalignment were recruited from the community in Melbourne, Australia. Quantitative gait analyses were conducted during walking trials at self-selected speeds, under three test conditions in a randomized order: i) no brace; ii) unadjusted brace (sagittal plane support, no varus adjustment); and iii) adjusted brace (sagittal plane support with varus adjustment). Participants rated their average level of knee pain on visual analogue scales upon completion of each test condition. Postprocessing of gait data involved calculation of knee kinematics, ground reaction forces and external joint moments for the reconstructed limb. First and second peak values were identified during stance phase. Data were statistically analyzed using repeated measures analysis of variance (p<0.05). Results: The cohort consisted of 15 (79%) males (meanAESD age 37AE7yrs, height 1.72AE0.06m, body weight 80AE10kg; KOOS subscales: pain 80AE15, symptoms 74AE13, activities of daily living 88AE15, sport/ recreation 69AE26, quality of life 58AE23). There were no significant differences in knee pain between the three test conditions (p¼0.655). Compared to the no brace condition, the adjusted brace resulted in immediate increases in the first peak knee flexion angle (mean difference, 95% confidence interval: -3.2 , -5.0 to -1.3) and moment at peak 1 (-1.0 Nm/kg, -1.5 to -0.5) and peak 2 (-0.8 Nm/kg, -1.3 to -0.4), increases in peak 1 and peak 2 knee adduction angles (-2.5 , -3.6 to -1.3; 2.6 , -3.7 to -1.4, respectively) and moments (-0.7 Nm/kg, -1.0 to -0.5; -0.7 Nm/kg, -1.0 to -0.4, respectively). Increases in peak 1 and peak 2 knee internal rotation angles (2.9 , 1.9 to 3.8; 3.3 , 2.1 to 4.6, respectively) and reduction in peak 1 internal rotation moment (-0.08 Nm/kg, -0.13 to -0.02) were noted with the adjusted brace. The unadjusted brace produced similar immediate changes in knee kinematics and moments. The unadjusted brace increased peak 1 knee flexion angle (-3.4 , -5.0 to -1.8) and moment (-1.2 Nm/kg, -1.7 to -0.7), increased both knee adduction angle peaks (peak 1: -2.0 , -3.2 to -0.9; peak 2: -2.3, -3.4 to -1.2) and moment peaks (peak 1: -0.7 Nm/kg, -1.0 to -0.4; peak 2: -0.8 Nm/kg, -1.3 to -0.4). The unadjusted brace also reduced peak 1 and peak 2 internal rotation angles (1.5 , 0.7 to 2.3; 2.4 , 1.3 to 3.6, respectively) and increased peak 1 internal rotation moment (-0.1 Nm/kg, -0.2 to -0.04). Compared to the unadjusted brace, the adjusted brace produced significantly reductions in both peak internal rotation angles (peak 1: -1.4 , -1.9 to -0.9; peak 2: -0.9 , -1.5 to -0.2 ( Figure 1) . Conclusion: Knee bracing significantly increased peak sagittal and frontal plane kinematics and moments at the knee joint, and reduced peak transverse plane kinematics and increased transverse plane moments in people with knee OA after ACLR. The varus adjusted brace produced more pronounced changes in frontal and transverse plane kinematics than the unadjusted brace. In younger individuals with predominant lateral knee OA and valgus malalignment after ACLR, the varus unloader brace may be able to mitigate abnormal knee joint mechanics. The long-term effect of this on progression of lateral compartment degenerative joint disease following ACLR requires further investigation. Purpose: Aging is a main risk factor for osteoarthritis (OA), the most prevalent musculoskeletal disorder. Aging-associated changes in autophagy, an essential cellular homeostasis mechanism, have recently been observed in several tissues, including articular cartilage. The objective of this study is to establish the patterns of autophagy in young and aging cartilage using GFP-LC3 mice. Methods: Morphological changes in the articular cartilage, Synovial inflammation and bone changes were examined by histology using a semiquantitative scoring systems. Furthermore, cellularity was determined by Hematoxylin-Eosine staining (H&E) and expression of the autophagy proteins Atg5 and LC3 was analyzed by immunohistochemistry (IHC) in 6, 18, 24 and 28 months old mice. In GFP-LC3 transgenic mice, GFP-LC3 is ubiquitously expressed under the control of CAG promoter, and the accumulation of GFP punctate, which represents autophagosome, is observed in almost all tissues after 24-48 h fasting period. Homozygous GFP-LC3 mice (tg/tg) were employed to monitore autophagy in liver and joint tissues in response to aging (6 months old and 28 months old mice) by confocal microscopy analysis of vibratome sections. Two sets of control mice were included: Wild-type C57BL/6J mice were used to determine the background level of green fluorescence and young homozygous GFP-LC3 mice (6 months old) to provide a baseline for autophagy activity in liver and joints. Results: The histological evaluation showed a significant increase in cartilage score, synovial inflammation and bone changes (P <0.05) in the old mice compared to the young control group. These results were accompanied with a reduction on cartilage cellularity and with a decrease in the expression of Atg5 and LC3 in an age-dependent manner, indicating a correlation between autophagy defects and agingrelated OA in mice. GFP-LC3 mice from 6 and 28 months old were employed to analyze the effect of aging on autophagy activation in liver and cartilage in the knee joints. In response to aging (28 months old mice), we observed a reduction in the GFP-LC3 signal in liver and cartilage. This reduction was statistically significant based on the total number of vesicles per cell (P < 0.01) and on the total area of vesicles per cell (um2) (P < 0.01) compared to the control group (6 months old mice). Conclusion: These results support the hypothesis that autophagy is decreased with aging and that compromised autophagy represents a novel mechanism in the development of OA. Purpose: Pain is the foremost clinical symptom of osteoarthritis (OA), however the processes that lead to pain in the joint are poorly understood. We have previously shown that nerve growth factor (NGF) is regulated in the joints of mice at the time they get OAinduced pain and NGF neutralisation is an effective analgesia (McNamee et al. 2010) . In pharmaceutical trials of monoclonal anti NGF antibodies, clinical efficacy in the treatment of OA pain has been demonstrated (Lane et al. 2010) but a small minority of patients developed accelerated disease, raising the possibility that analgesia per se, or anti-NGF specifically, contributes to disease progression. This might occur by removing the mechanical protection afforded by painful behaviour, or be due to a direct disease modifying effect of the antibody. The purpose of this study was to investigate the regulation of NGF in painful murine OA joints, specifically focusing on where it is regulated and its induction following mechanical injury. The dependence of NGF on FGF2, a cytokine released upon cartilage injury, was also examined. Finally, we modelled the effects of chronic NGF neutralisation or indomethacin (a non-steroidal anti-inflammatory agent) on disease progression in murine OA. Methods: Surgical joint destabilisation, a validated model of OA, was performed on 10 week old male or female mice and painful behaviour (a combination of Von Frey, cold plate sensitivity, analgesymeter and Linton incapacitance) assessed weekly. RNA was isolated from whole knee joints or micro-dissected tissues (articular cartilage, meniscus and epiphysis). For cartilage injury responses in vitro, RNA was isolated from hip epiphyses of 5 week old wild type or FGF2 knockout mice. Additional injury studies were performed on porcine cartilage that had been pre-incubated with the FGF receptor inhibitor SB402451. Anti NGF, indomethacin or relevant controls were administered to wild type OA mice from the time of pain onset for a further 6 weeks. The analgesic response to anti-NGF was measured. Joints were sectioned and scored. Results: NGF was regulated in whole murine joints at the time the mice developed pain. When micro-dissected tissues were examined separately, NGF was specifically regulated in the articular cartilage and not in the bone or meniscus. NGF was strongly regulated (>200 fold) upon in vitro cartilage injury. In vitro injury-induced NGF was dependent upon FGF2, as the induction was suppressed when FGF2 knockout cartilage was explanted, and when porcine cartilage was pre-incubated with the FGF receptor inhibitor prior to injury. Despite the dependence of NGF on FGF2 in vitro, FGF2 knockout mice still developed anti-NGF sensitive pain following joint destabilisation and pain in these mice occurred earlier than in wild type mice in keeping with their more severe cartilage injury scores (Chia et al 2009). Neutralising NGF for 6 weeks in mice with painful OA produced sustained analgesia but did not alter the severity of cartilage degradation over this time. Similarly, chronic dosing with indomethacin had no apparent disease modifying effects. Conclusions: NGF is a validated pain target in murine OA and is regulated largely within the articular cartilage in vivo and upon cartilage injury in vitro. Cartilage injury-induced NGF in vitro was strongly FGF2 dependent, but this did not seem to be the case in vivo. Indeed, FGF2 knockout mice developed earlier pain, apparently correlating with accelerated disease seen in this strain. We were unable to demonstrate any differences in disease progression between mice chronically dosed with analgesics and those with pain over this period of study. Purpose: Adamts-5 null mice are protected from cartilage degeneration and accompanying mechanical allodynia in experimental osteoarthritis induced by destabilization of the medial meniscus (DMM). A highly selective and potent monoclonal antibody (Ab) that neutralizes ADAMTS-5 was able to mimic these findings when administered prophylactically through 8 weeks post DMM surgery. The goal of the current study was to test whether this Ab can provide similar beneficial effects when administered in a therapeutic setting, i.e., after onset of joint pathological changes and mechanical allodynia. The therapeutic effects of anti-ADAMTS-5 on progression of joint damage, mechanical allodynia in the hindpaw, and concomitant molecular changes in the nociceptive pathway were analyzed. Methods: DMM surgery was performed in the right knees of 10-week old male C57BL/6 mice. Four weeks later, mice were administered weekly injections of anti-ADAMTS-5 or IgG isotype control Ab (i.p. 10 mg/kg). Untreated mice served as an additional control group. For the next 12 weeks, mice were monitored bi-weekly for mechanical allodynia in the ipsilateral hind paw using von Frey fibers and the up-down staircase technique. Sixteen weeks post DMM, mice were taken down (n¼11-12), and knees were collected for histopathology according to OARSI recommendations. Total joint score is a sum of cartilage degeneration and osteophyte formation on both the lateral and medial sides of the joint, with a maximum possible score for cartilage degeneration ¼ 60, and osteophyte formation ¼ 6 (max total joint score ¼ 66). Additionally, subchondral bone sclerosis in the medial compartment was assessed, using a bone score with a maximum score of 5. In addition, a set of n¼4 mice/treatment group were taken down 8 weeks after surgery. Ipsilateral knee innervating dorsal root ganglia (DRG) L3-L5 were harvested, and sensory neurons were isolated and cultured for 4 days. Cell culture supernatants were analyzed for the pro-algesic chemokines, MCP-1 and fractalkine, via ELISA. Results: Histopathology of the knee joint 16 weeks post surgery revealed that untreated mice developed moderate levels of cartilage degeneration and osteophyte formation (total joint score ¼ 19.3AE3.1) and subchondral bone sclerosis (bone score ¼ 2.5AE0.7). When anti-ADAMTS5 was administered beginning at 4 weeks post DMM, mice were protected against cartilage degeneration and osteophyte formation (total joint score ¼ 9.5AE2.0) (p¼0.02), but not against subchondral bone changes (bone score ¼ 2.6AE0.3) (p¼0.92) by 16 weeks post surgery. IgG isotype control Ab afforded some protection against change in the total joint score, but this was not statistically significant compared to untreated DMM mice (total joint score ¼ 13.1AE3.0) (p¼0.2). Four weeks after DMM surgery, mice presented with robust mechanical allodynia in the ipsilateral hind paw, an indicator of sensitization in the pain pathway. In untreated mice and in mice receiving IgG isotype control Ab, the allodynia was maintained through 16 weeks post surgery (p<0.0001). In mice treated with anti-ADAMTS-5, the allodynia resolved and this protection lasted through 12 weeks post surgery. By 16 weeks post surgery, mechanical allodynia had returned (p<0.05) (Fig 1) . Eight weeks after surgery, innervating DRG neurons from untreated DMM mice produced elevated levels of MCP-1 and fractalkine protein compared to naïve and sham mice. When DRG neurons were cultured from mice treated with anti-ADAMTS5 between weeks 4 and 8 post DMM, the levels of MCP-1 and fractalkine were significantly downregulated compared to untreated mice (p<0.01). This downregulation reflects decreased activation of sensory neurons and correlates with decreased mechanical allodynia after treatment with anti-ADAMTS-5. Conclusions: This study demonstrates therapeutic efficacy of a potent and selective anti-ADAMTS-5 Ab in the DMM model, when administered in early stages of disease. Therapeutic effect on cartilage degeneration, mechanical allodynia as an indicator of pain and concomitant molecular changes in sensory neurons further supports the idea that structural joint damage and development of pain are linked. These studies will help elucidate whether slowing progression of joint damage can prevent or slow the development of pain. Ongoing experiments are evaluating therapeutic effect of ADAMTS-5 blockade in late stage experimental osteoarthritis.
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